Expanding transcatheter aortic valve replacement into uncharted indications.

Author: Guson KANG ¹ ; Juyong Brian KIM
Author Information

1. Division of Cardiovascular Medicine, Department of Medicine and Cardiovascular Institute, Stanford University, Stanford, CA, USA. kimjb@stanford.edu
Publication Type:Review
Keywords: Transcatheter aortic valve replacement; Indications; Aortic valve stenosis
MeSH: Aortic Valve; Aortic Valve Stenosis; Humans; Prostheses and Implants; Transcatheter Aortic Valve Replacement*
From:The Korean Journal of Internal Medicine 2018;33(3):474-482
CountryRepublic of Korea
Language:English
Abstract: Since the first-in-man transcatheter delivery of an aortic valve prosthesis in 2002, the landscape of aortic stenosis therapeutics has shifted dramatically. While initially restricted to non-surgical cases, progressive advances in transcatheter aortic valve replacement and our understanding of its safety and efficacy have expanded its use in intermediate and possibly low surgical risk patients. In this review, we explore the past, present, and future of transcatheter aortic valve replacement.